Malaysia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Malaysia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 1.9% year on year. In 2019, the country was ranked number 83 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 350 Cases. Malaysia is overtaken by Somalia, which was number 82 with 353 Cases and is followed by Lesotho at 340 Cases. India ranked the highest with 66,255 Cases in 2019, an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 350.00 |
2018 | 333.00 |
2017 | 352.00 |
2016 | 201.00 |
2015 | 223.00 |
How does Malaysia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
81 |
#81
Georgia
|
364 | 2019 | +0.0 % | -3.8 % | View data | |
83 |
#83
Malaysia
|
350 | 2019 | +5.1 % | +1.9 % | View data | |
84 |
#84
Lesotho
|
340 | 2019 | +4.6 % | +18.1 % | View data |